Expanding markets in a developing continent
This article was originally published in Clinica
Chile's medical device market grew 15% in 1995 to reach $275 million, outperforming its continental neighbour, Colombia. In its 1996 Emerging Nations Report, HIMA charts both countries' systems and indicates how health policies have changed in recent years hand-in-hand with economic stability.
You may also be interested in...
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
Sandoz Canada has become the first manufacturer to launch generic versions of posaconazole and silodosin in Canada. The company launched the generic version of Allergan’s Rapaflo (silodosin) after a Canadian court ruled that Sandoz did not infringe a key formulation patent.
US healthcare insurance provider Health Net failed to respect Amarin’s patent rights in the way it distributed Hikma’s generic version of Vascepa (icosapent ethyl), the originator contends in an expanded induced infringement suit.